{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T18:34:53Z","timestamp":1772217293936,"version":"3.50.1"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.lfs.2020.118643","type":"journal-article","created":{"date-parts":[[2020,10,24]],"date-time":"2020-10-24T10:36:04Z","timestamp":1603535764000},"page":"118643","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Effects of rapamycin and AZD3463 combination on apoptosis, autophagy, and cell cycle for resistance control in breast cancer"],"prefix":"10.1016","volume":"264","author":[{"given":"Neslihan P\u0131nar","family":"Ozates","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatma","family":"So\u011futlu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ferzan","family":"Lermioglu Erciyas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Busra","family":"Demir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cumhur","family":"Gunduz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Behrouz","family":"Shademan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cigir Biray","family":"Avci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.lfs.2020.118643_bb0005","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s13045-019-0783-9","article-title":"Incidence and death in 29 cancer groups in 2017 and trend analysis from 1990 to 2017 from the Global Burden of Disease Study","volume":"12","author":"Lin","year":"2019","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.lfs.2020.118643_bb0010","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.10992.1","article-title":"Resistance mechanisms to drug therapy in breast cancer and other solid tumors: an opinion","volume":"6","author":"Moiseenko","year":"2017","journal-title":"F1000Research"},{"key":"10.1016\/j.lfs.2020.118643_bb0015","first-page":"1864","article-title":"Breast cancer molecular subtypes: from TNBC to QNBC","volume":"6","author":"Hon","year":"2016","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.lfs.2020.118643_bb0020","doi-asserted-by":"crossref","DOI":"10.14366\/usg.16030","article-title":"Molecular subtypes and imaging phenotypes of breast cancer","volume":"35","author":"Cho","year":"2016","journal-title":"Ultrasonography"},{"issue":"6","key":"10.1016\/j.lfs.2020.118643_bb0025","doi-asserted-by":"crossref","first-page":"961","DOI":"10.3889\/oamjms.2018.231","article-title":"Presentation of the molecular subtypes of breast cancer detected by immunohistochemistry in surgically treated patients","volume":"6","author":"Kondov","year":"2018","journal-title":"Open Access Macedonian Journal of Medical Sciences"},{"key":"10.1016\/j.lfs.2020.118643_bb0030","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1159\/000481657","article-title":"PI3K\/mTOR inhibitors in the treatment of luminal breast cancer. Why, when and to whom?","volume":"12","author":"Schettini","year":"2017","journal-title":"Breast Care"},{"key":"10.1016\/j.lfs.2020.118643_bb0035","doi-asserted-by":"crossref","first-page":"e22547","DOI":"10.1002\/jbt.22547","article-title":"Effects of metformin and pioglitazone combination on apoptosis and AMPK\/mTOR signaling pathway in human anaplastic thyroid cancer cells","author":"Ozdemir Kutbay","year":"2020","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"10.1016\/j.lfs.2020.118643_bb0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13578-020-00416-0","article-title":"Roles of the PI3K\/AKT\/mTOR signalling pathways in neurodegenerative diseases and tumours","volume":"10","author":"Xu","year":"2020","journal-title":"Cell & Bioscience"},{"key":"10.1016\/j.lfs.2020.118643_bb0045","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/9258396","article-title":"Signal transduction pathways in breast cancer: the important role of PI3K\/Akt\/mTOR","volume":"2020","author":"Ortega","year":"2020","journal-title":"Journal of Oncology"},{"key":"10.1016\/j.lfs.2020.118643_bb0050","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2019.01326","article-title":"Autophagy machinery as a promising therapeutic target in endometrial cancer","volume":"9","author":"Nu\u00f1ez-Olvera","year":"2019","journal-title":"Front. Oncol."},{"key":"10.1016\/j.lfs.2020.118643_bb0055","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/onc.2015.79","article-title":"mTOR inhibitors induce apoptosis in colon cancer cells via CHOP-dependent DR5 induction on 4E-BP1 dephosphorylation","volume":"35","author":"He","year":"2016","journal-title":"Oncogene"},{"key":"10.1016\/j.lfs.2020.118643_bb0060","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/686984","article-title":"mTOR signaling in protein translation regulation: implications in cancer genesis and therapeutic interventions","volume":"2014","author":"Showkat","year":"2014","journal-title":"Molecular Biology International"},{"key":"10.1016\/j.lfs.2020.118643_bb0065","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1002\/jcp.22647","article-title":"Therapeutic resistance resulting from mutations in Raf\/MEK\/ERK and PI3K\/PTEN\/Akt\/mTOR signaling pathways","volume":"226","author":"McCubrey","year":"2011","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.lfs.2020.118643_bb0070","doi-asserted-by":"crossref","first-page":"3491","DOI":"10.3390\/ijms19113491","article-title":"Receptor tyrosine kinase-targeted cancer therapy","volume":"19","author":"Yamaoka","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2020.118643_bb0075","doi-asserted-by":"crossref","first-page":"a001115","DOI":"10.1101\/mcs.a001115","article-title":"ALK: a tyrosine kinase target for cancer therapy","volume":"3","author":"Holla","year":"2017","journal-title":"Cold Spring Harb. Mol. Case Stud."},{"key":"10.1016\/j.lfs.2020.118643_bb0080","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s41408-018-0169-1","article-title":"The ALK inhibitor AZD3463 effectively inhibits growth of sorafenib-resistant acute myeloid leukemia","volume":"9","author":"Moharram","year":"2019","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.lfs.2020.118643_bb0085","article-title":"Novel ALK inhibitor AZD3463 inhibits neuroblastoma growth by overcoming crizotinib resistance and inducing apoptosis","volume":"6","author":"Wang","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.lfs.2020.118643_bb0090","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1038\/aps.2015.68","article-title":"Toward rapamycin analog (rapalog)-based precision cancer therapy","volume":"36","author":"Meng","year":"2015","journal-title":"Acta Pharmacol. Sin."},{"issue":"8","key":"10.1016\/j.lfs.2020.118643_bb0095","doi-asserted-by":"crossref","first-page":"172","DOI":"10.5306\/wjco.v9.i8.172","article-title":"Current status of PI3K-mTOR inhibition in hormone-receptor positive, HER2-negative breast cancer","volume":"9","author":"Sobhani","year":"2018","journal-title":"World Journal of Clinical Oncology"},{"key":"10.1016\/j.lfs.2020.118643_bb0100","doi-asserted-by":"crossref","first-page":"27055","DOI":"10.18632\/oncotarget.7446","article-title":"mTOR inhibitors, a new era for metastatic luminal HER2-negative breast cancer? A systematic review and a meta-analysis of randomized trials","volume":"7","author":"Rotundo","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.lfs.2020.118643_bb0105","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.molcel.2008.06.007","article-title":"mTOR and Akt signaling in cancer: SGK cycles","volume":"31","author":"Toker","year":"2008","journal-title":"In. Mol. Cell"},{"key":"10.1016\/j.lfs.2020.118643_bb0110","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0092-8674(94)90573-8","article-title":"p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21","volume":"78","author":"Toyoshima","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.lfs.2020.118643_bb0115","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1747-1028-4-2","article-title":"The function of APC\/CCdh1 in cell cycle and beyond","volume":"4","author":"Li","year":"2009","journal-title":"Cell Div"},{"key":"10.1016\/j.lfs.2020.118643_bb0120","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/84879","article-title":"Pten and p27KIP1 cooperate in prostate cancer tumor suppression in the mouse","volume":"27","author":"Di Cristofano","year":"2001","journal-title":"Nat. Genet."},{"key":"10.1016\/j.lfs.2020.118643_bb0125","doi-asserted-by":"crossref","first-page":"6199","DOI":"10.1073\/pnas.96.11.6199","article-title":"PTEN modulates cell cycle progression and cell survival by regulating phosphatidylinositol 3,4,5,-trisphosphate and Akt\/protein kinase B signaling pathway","volume":"96","author":"Sun","year":"1999","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.lfs.2020.118643_bb0130","doi-asserted-by":"crossref","DOI":"10.3390\/nu10081043","article-title":"Pectolinarigenin induced cell cycle arrest, autophagy, and apoptosis in gastric cancer cell via PI3K\/AKT\/mTOR signaling pathway","volume":"10","author":"Lee","year":"2018","journal-title":"Nutrients"},{"key":"10.1016\/j.lfs.2020.118643_bb0135","doi-asserted-by":"crossref","first-page":"5993","DOI":"10.18632\/oncotarget.23202","article-title":"Inhibition of IAP’s and activation of p53 leads to caspase-dependent apoptosis in gastric cancer cells treated with Scutellarein","volume":"9","author":"Saralamma","year":"2018","journal-title":"Oncotarget"},{"issue":"12","key":"10.1016\/j.lfs.2020.118643_bb0140","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.3390\/cancers11121858","article-title":"FoxO3a as a positive prognostic marker and a therapeutic target in Tamoxifen-resistant breast cancer","volume":"11","author":"Pellegrino","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.lfs.2020.118643_bb0145","doi-asserted-by":"crossref","first-page":"3948","DOI":"10.4161\/cc.10.22.18124","article-title":"High-dose rapamycin induces apoptosis in human cancer cells by dissociating mTOR complex 1 and suppressing phosphorylation of 4E-BP1","volume":"10","author":"Yellen","year":"2011","journal-title":"Cell Cycle"},{"key":"10.1016\/j.lfs.2020.118643_bb0150","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.9207.1","article-title":"mTOR inhibitors in cancer therapy","volume":"5","author":"Xie","year":"2016","journal-title":"F1000Research"},{"key":"10.1016\/j.lfs.2020.118643_bb0155","article-title":"Novel ALK inhibitor AZD3463 inhibits neuroblastoma growth by overcoming crizotinib resistance and inducing apoptosis","volume":"6","author":"Wang","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.lfs.2020.118643_bb0160","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1038\/s41419-018-1054-3","article-title":"Apatinib-induced protective autophagy and apoptosis through the AKT\u2013mTOR pathway in anaplastic thyroid cancer","volume":"9","author":"Feng","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.lfs.2020.118643_bb0165","doi-asserted-by":"crossref","first-page":"3961","DOI":"10.2147\/DDDT.S181939","article-title":"Baicalein induces apoptosis and autophagy of breast cancer cells via inhibiting PI3K\/AKT pathway in vivo and vitro","volume":"12","author":"Yan","year":"2018","journal-title":"Drug Des. Devel. Ther."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320520313965?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320520313965?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T07:30:44Z","timestamp":1754465444000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320520313965"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":33,"alternative-id":["S0024320520313965"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2020.118643","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of rapamycin and AZD3463 combination on apoptosis, autophagy, and cell cycle for resistance control in breast cancer","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2020.118643","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"118643"}}